Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Cancer of unknown primary site with epidermal growth factor receptor mutation for which gefitinib proved effective].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Aug 2012

Yamada Tadaaki, Ohtsubo Koushiro, Ishikawa Daisuke, Nanjo Shigeki, Takeuchi Shinji, Mouri Hisatsugu, Yamashita Kaname, Yasumoto Kazuo, Yano Seiji

Abstract excerpt

We report a 53-year-old man with cancer of an unknown primary site with an epidermal growth factor receptor mutation for which gefitinib was effective. In 2007, he complained of left gluteal pain and right cervical lymph node swelling. He was given a diagnosis of adenocarcinoma at the biopsy of the right cervical lymph node. Although metastases of multiple lymph nodes, bone, and bilateral adrenal glands were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antineoplastic Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biopsy

Share to ErbB Receptors

Share to Gefitinib

Share to Neoplasms, Unknown Primary

Share to Quinazolines

Share to Tomography, X-Ray Computed

Source

Identifiers

PMID: 22902462

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Cancer of unknown primary site with epidermal growth factor receptor mutation for which gefitinib proved effective].PMID 22902462Read ↗

Putative lung adenocarcinoma with epidermal growth factor receptor mutation presenting as carcinoma of unknown primary site: A case report.Semantic proximity Read ↗

Diagnosis and management of metastatic neoplasms with unknown primary.Semantic proximity Read ↗

Complex Differential Diagnosis between Primary Breast Cancer and Breast Metastasis from EGFR-Mutated Lung Adenocarcinoma: Case Report and Literature Review.Semantic proximity Read ↗

Cancer of Unknown Primary SiteSemantic proximity Read ↗

[Efficacy of gefitinib for young patients with unknown EGFR gene mutation in advanced lung adenocarcinoma].Semantic proximity Read ↗

Bone metastatic carcinoma with EGFR amplification and mutation: A case report and literature review.Semantic proximity Read ↗

The unknown biology of the unknown primary tumour: a literature review.Semantic proximity Read ↗

Cancer of unknown primary site: 20 questions to be answeredSemantic proximity Read ↗

[Erlotinib plus Bevacizumab Therapy for Postoperative Recurrence of Adenosquamous Cell Carcinoma Harboring EGFR Mutation-A Case Report].Semantic proximity Read ↗

[Assessing the usefulness of erlotinib in patients with unknown or negative epidermal growth factor receptor mutation status].Semantic proximity Read ↗

Adenoid Cystic Carcinoma of the Lung with an EGFR Mutation.Semantic proximity Read ↗

[Carcinoma of unknown primary. Case no. 4].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.